Literature DB >> 6321792

Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.

T Gardella, P Medveczky, T Sairenji, C Mulder.   

Abstract

A simple gel technique is described for the detection of large, covalently closed, circular DNA molecules in eucaryotic cells. The procedure is based on the electrophoretic technique of Eckhardt (T. Eckhardt, Plasmid 1:584-588, 1978) for detecting bacterial plasmids and has been modified for the detection of circular and linear extrachromosomal herpesvirus genomes in mammalian cells. Gentle lysis of suspended cells in the well of an agarose gel followed by high-voltage electrophoresis allows separation of extrachromosomal DNA from the bulk of cellular DNA. Circular viral DNA from cells which carry the genomes of Epstein-Barr virus, Herpesvirus saimiri, and Herpesvirus ateles can be detected in these gels as sharp bands which comigrate with bacterial plasmid DNA of 208 kilobases. Epstein-Barr virus producer cell lines also show a sharp band of linear 160-kilobase DNA. The kinetics of the appearance of this linear band after induction of viral replication after temperature shift parallels the known kinetics of Epstein-Barr virus production in these cell lines. Hybridization of DNA after transfer to filters shows that the circular and linear DNA bands are virus specific and that as little as 0.25 Epstein-Barr virus genome per cell can be detected. The technique is simple, rapid, and sensitive and requires relatively low amounts of cells (0.5 X 10(6) to 2.5 X 10(6)).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321792      PMCID: PMC255605     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.

Authors:  A Adams; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

5.  Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1.

Authors:  T Nagoya; Y Hinuma
Journal:  Gan       Date:  1972-02

6.  Replication of herpes-type virus in a Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; J T Grace
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

7.  Small polydisperse circular DNA of HeLa cells.

Authors:  C A Smith; J Vinograd
Journal:  J Mol Biol       Date:  1972-08-21       Impact factor: 5.469

8.  The gel electrophoresis of DNA.

Authors:  C Aaij; P Borst
Journal:  Biochim Biophys Acta       Date:  1972-05-10

9.  Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

10.  Characterization of IgG-containing DEAE fractions of canine serum.

Authors:  C Whitacre; R W Lang
Journal:  Transplant Proc       Date:  1975-12       Impact factor: 1.066

View more
  143 in total

1.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.

Authors:  M A Lee; M E Diamond; J L Yates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth.

Authors:  M S Kang; S C Hung; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

4.  Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  V Varthakavi; P J Browning; P Spearman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  Jill T Bechtel; Yuying Liang; Joshua Hvidding; Don Ganem
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

6.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

7.  Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity.

Authors:  C N Yandava; S H Speck
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

8.  Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses.

Authors:  J L Kolman; C J Kolman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.

Authors:  A Marchini; R Longnecker; E Kieff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.

Authors:  A Marchini; J I Cohen; F Wang; E Kieff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.